Target Healthcare REIT (LON:THRL) Sets New 1-Year High – Still a Buy?

Target Healthcare REIT (LON:THRL)’s share price hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 117 and last traded at GBX 116.40, with a volume of 2054494 shares changing hands. The stock had previously closed at GBX 116.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reiterated a “hold” rating and issued a GBX 101 target price on shares of Target Healthcare REIT in a research note on Wednesday, May 6th. One research analyst has rated the stock with a Hold rating, According to MarketBeat, Target Healthcare REIT currently has an average rating of “Hold” and an average target price of GBX 101.

Target Healthcare REIT Price Performance

The stock’s 50-day moving average price is GBX 108.85 and its 200 day moving average price is GBX 105.66. The firm has a market capitalization of £720.72 million, a PE ratio of 9.24, a price-to-earnings-growth ratio of 1.48 and a beta of 0.70.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.